El Hospital Universitario Son Dureta era un centro médico, universitario y público perteneciente al Servicio de Salud de las Islas Baleares Estaba ubicado en el distrito Poniente de Palma de Mallorca, concretamente en el barrio homónimo.

During the past decade, Hospital Son Dureta conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Son Dureta" #1 sponsor was "PETHEMA Foundation" with 9 trials, followed by "Sociedad Española de Neumología y Cirugía Torácica" with 4 trials sponsored, "Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular" with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored and "Ipsen" with 2 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Son Dureta" #1 collaborator was "Fondo de Investigacion Sanitaria" with 3 trials as a collaborator, "Fundacion Caubet-Cimera Islas Baleares" with 3 trials as a collaborator, "Abbott Medical Devices" with 2 trials as a collaborator, "B.Braun Surgical SA" with 2 trials as a collaborator and "Hospital San Carlos, Madrid" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Son Dureta" are "Acute Lymphoblastic Leukemia" (4 trials), "HIV Infections" (3 trials), "Aneurysmal Subarachnoid Hemorrhage" (2 trials), "Breast Cancer" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Hospital Son Dureta" in a lesser frequency.

Most popular intervention types in "Hospital Son Dureta" are "Drug" (40 trials), "Device" (8 trials), "Procedure" (5 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "CPAP (Continuous Positive Airway Pressure)" (2 trials), "Coronary angioplasty using the paclitaxel-eluting balloon" (2 trials), "Everolimus Eluting Coronary Stent System" (2 trials) and "chemotherapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Son Dureta" are 46 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Son Dureta". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Hospital Son Dureta, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Son Dureta, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 5 trials that are defined as “Not Applicable".